There may be some inappropriate images on these informative pages, please acknowledge that you are 18 yrs or older.

agree    cancel

PDL VBeam®

For a consult please call our cosmetic concierge at 1-855-793-2868

The Vbeam® Pulsed Dye Laser (PDL) uses a beam of light at a specific wavelength and is used for conditions or spots on the skin which are made up of blood and blood vessels. This laser can be used for all ages and all skin types.


Vascular Lesions – Port wine stains, facial and leg veins, rosacea, angiomas, hemangiomas, venous lakes, scars, stretch marks, warts and benign gynecological vascular lesions

Psoriasis – Treats even the most resistant psoriasis

Wrinkles – Treat full-face wrinkles with the Vbeam to slow the aging process

Acne – Vbeam treats the bacteria that causes acne, as well as the diffuse redness and swelling that often comes along with the condition, resulting in clear, blemish-free skin

More solutions

The versatility of the Vbeam laser allows for treatment of a wide range of vascular lesions, including: periorbital wrinkles, facial veins, rosacea, leg veins, port wine stains, hemangiomas, scars, stretch marks, and warts.

More flexibility and convenience

Vbeam’s user-selectable pulse duration allows for greater control by the physician. Cosmetic procedures can be done quickly, and with no down time.

Greater comfort

The VBeam’s patented Dynamic Cooling DeviceT (DCDT) sprays cryogen onto the epidermis prior to each laser pulse for quick and effective cooling and protection of the epidermis. This patented protection technology maximizes patient safety and comfort. In addition, the VBeam’s innovative ultra-long pulse duration – the longest offered in a dye laser – delivers laser energy to targeted blood vessels over longer periods of time, resulting in a more gentle heating effect and uniform coagulation. By heating targeted vessels more gently, Vbeam eliminates postoperative purpura, or bruising.

View more RealSelf Rosacea Treatment videos



Rosacea/Facial Telangiectasia

PDL VBeam, Rosacea/Facial Telangiectasia Before and After Treatment

Vbeam Studies and Publications


Clinical Bulletin #1

“Vbeam Pulsed Dye Laser Treatment of Poikiloderma of Civatte” by Dr. Stephen Eubanks. This study demonstrates a 75+% improvement in patients without purpura or side-effects.

Clinical Bulletin #2

“Vbeam Pulsed Dye Laser Treatment of Facial Rosacea” by Drs. Dover and Alam. This bulletin explains how Vbeam enables dramatic purpura-free treatments of rosacea.

Clinical Bulletin #3

“Vbeam Pulsed Dye Laser Treatment of Wrinkles” by Dr. David Bank. This study concludes that treatment with the Vbeam laser offers a particularly appealing compromise between therapeutic efficacy and lack of side effects.

Clinical Bulletin #4

“Vbeam Pulsed Dye Laser Treatment of Leg Telangiectasia” by Dr. Luigi Polla, explains that 70% and more clearance was obtained in 66.6% of patients…of these patients, 64.4% of the clearance was obtained after the first treatment.”

Clinical Bulletin #5

“Vbeam Pulsed Dye Laser Treatment of PWS in the context of Sturge Weber Syndrome” by Dr. Gerald Goldberg. The study shows that the child’s condition improved dramatically, and she had a very gratifying response after only a few treatments.

Clinical Bulletin #6

“Vbeam Pulsed Dye Treatment of Rosacea” by Dr. David Laub states that prior to Vbeam as an option, patients were much more adverse to treating rosacea with lasers due to the severe purpura, but now the long pulsed dye Vbeam is an acceptable treatment modality.

Clinical Bulletin #7

“Vbeam Pulsed Dye Treatment of Wrinkles” by Dr. Dennis Nigro. Dr. Nigro concludes that of the 75 patients treated, all saw significant improvement in skin tone and texture, a reduction in the appearance of fine lines and wrinkles, and a reduction in the number of visible facial vessels.

Clinical Bulletin #8

“Vbeam Treatment of Post-Acne Redness” by Dr. Wichai Hongcharu. This study shows that patients benefited from a 30-50% reduction in acne redness after the first treatment, and 75-90% reduction was achieved after 3-4 treatments.

Clinical Bulletin #9

“Vbeam Treatment of Warts” by Dr. Catherine Smadja discusses various treatment modalities for wars, and why Vbeam is such a viable option.

Clinical Bulletin #10

“Vbeam Pulsed Dye Treatment of Periorbital Rhytides” by Dr. Suzanne Kilmer proves that Vbeam offers an excellent option for physicians whose patients are looking for a soft and non-ablative approach to periorbital wrinkle treatment.

Clinical Bulletin #11

“Vbeam Treatment of Port Wine Stains” by Dr. Thomas Rohrer discusses how the Vbeam’s longer wavelength and pulse duration, as well as larger spot size and higher fluence allow for more optimal clearing of a port wine stain than with previous pulsed dye technology.

Clinical Bulletin #12

“The Expanding Role of Vbeam in our Practice” by Drs. Miller and Selzer discusses why Vbeam is considered the workhorse of their practice, as well as a key element to numerous combination treatment approaches.

Clinical Bulletin #13

“Vbeam Treatment of Superficial Wrinkles” by Dr. Monica Maluf discusses the safe and immediate results reached when treating wrinkles and overall tone.

Clinical Bulletin #14

“Vbeam Treatment of Facial Telangiectasia Using the Pulse Stacking Protocol” by Dr. Thomas Rohrer explains the technique of using stacked pulses of energy to reach optimal clinical endpoints with less trauma to the vessels.

Clinical Bulletin #15

“A Paired Comparision Analysis of Smoothbeam and Vbeam versus Vbeam Alone for Cutaneous Rejuventation” by Dr. Bruce Katz discusses how combining the Vbeam and Smoothbeam enables the user to cause both superficial changes as well as changes deeper within the skin, leading to more impressive overall results.

Clinical Bulletin #16

“Vbeam Treatment of Inflammatory Acne Vulgaris” by Dr. Louis Stolman demonstrates how Vbeam targets the bacteria that causes acne, resulting in impressive clearance in few treatments and little pain.


Clinical Paper #1

“The Effect of Pulse Duration on Facial Telangiectasia: a Comparison of the SPTL 1B and the Vbeam” by Dr. Steve Eugent talks about the differences between the two devices, and proves that equally impressive clearance is reached with Vbeam, without downtime.

Clinical Paper #2

“Laser Treatment of Leg Telangiectasia: a Comparative Study of Three Devices” by Dr. Michael Clinton explains that Vbeam enables treatments with more gentle heating of the targeted vessel, therefore little to no purpura, when compared to the Aura and the Versapulse.

Clinical Paper #3

“Perspectives on Innovations in Pulsed Dye Laser Development” by Dr. Jeffrey Dover demonstrates the different generations and applications that have occurred throughout the lifetime of pulsed dye technology.


Published Article 1

Stephen R. Tan, MD, FRCPC, and Whitney D. Tope, MPhil, MDb, “Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life”, J Am Acad Dermatol, October 2004.

Published Article 2

David J. Goldberg, MD, Dale Sarradet, MD, Mussarat Hussian, MD, Anna Krishtul, MD, and Robert Phelps, MD, “Clinical, Histologic, and Ultrastructural Changes after Nonablative Treatment with a 595-nm Flashlamp-Pumped Pulsed Dye Laser: Comparison of Varying Settings”, Dermatology Surgery, July 2004.

Published Article 3

Zaid F. Jasim, MRCP, Wai Jit Woo, MRCP, and Julian M. Handley, MD, FRCP, “Long-Pulsed (6-ms) Pulsed Dye Laser Treatment of Rosacea-Associated Telangiectasia Using Subpurpuric Clinical Threshold”, Dermatology Surgery, January 2004.

Published Article 4

Taro Kono, MD, Takashi Yamaki, MD, Ali Ryza Ercocen, MD, Osamu Fujiwara, MD, and Motohiro Nozaki, MD, “Treatment of Leg Veins With the Long Pulse Dye Laser Using Variable Pulse Durations and Energy Fluences”, Lasers in Surgery and Medicine, 2004.

Published Article 5

Jeffrey S. Orringer, MD, Sewon Kang, MD, Ted Hamilton, MS, Wendy Schumacher, BS, Soyun Cho, MD, PhD, Craig Hammerberg, PhD, Gary J. Fisher, PhD, Darius J. Karimipour, MD, Timothy M. Johnson, MD, John J. Voorhees, MD, “Treatment of Acne Vulgaris With a Pulsed Dye Laser, A Randomized Controlled Trial”, JAMA, June 2004.

Our Doctors in the News

Download Brochures

Our Patient Education Library

Click for office locations and phone numbers